Blog
RSS FeedPosted by Michael Wonder on 01 Feb 2021
Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding
2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient ...
Posted by Michael Wonder on 01 Feb 2021
EU export restrictions on COVID-19 vaccines may jeopardise global supply
1 February 2021 - Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of modern ...
Posted by Michael Wonder on 31 Jan 2021
New Zealand Pharmaceutical Schedule - 1 February 2021
1 February 2021 - The February 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Jan 2021
Government rejects claim overseas production issues threaten access to vaccines
27 January 2021 - The entire population could be vaccinated against COVID-19 in as little as 6½ months, meaning it's ...
Posted by Michael Wonder on 20 Jan 2021
COVID-19 vaccines and equity: some Kiwis may get more effective jabs than other
20 January 2021 - Questions have been raised about whether New Zealanders will have equitable access to COVID-19 vaccines, as ...
Posted by Michael Wonder on 19 Jan 2021
COVID-19 coronavirus: Ashley Bloomfield - vaccine approval just a couple of weeks away
20 January 2021 - The approval process for the Covid vaccine is on track to be granted in the coming ...
Posted by Michael Wonder on 19 Jan 2021
Medicines NZ hopes country can roll out COVID-19 vaccines early
19 January 2021 - Medical professionals are hopeful New Zealand is in a position to roll out COVID-19 vaccines early. ...
Posted by Michael Wonder on 18 Jan 2021
How NZ is preparing for the biggest vaccine roll-out in history
17 January 2021 - “When will we get a vaccine for COVID-19?” It has been the question on everyone’s lips for ...
Posted by Michael Wonder on 14 Jan 2021
COVID-19: NZ vaccine timeline remains the same in light of new variant strains
13 January 2021 - New Zealand does not have any plans to fast-track its Covid-19 vaccine roll-out in light of ...
Posted by Michael Wonder on 12 Jan 2021
From 1 February 2021 pre-COVID-19 Special Authority criteria will be reinstated
12 January 2020 - The temporary changes will remain in place for any Special Authority applications for the relevant medicines made ...
Posted by Michael Wonder on 12 Jan 2021
Decision to widen access to valganciclovir for transplant patients
12 January 2021 - PHARMAC is pleased to announce a decision to widen access to valganciclovir for use after lung ...
Posted by Michael Wonder on 11 Jan 2021
Evaluating New Zealanders’ values for drug coverage decision-making: trade-offs between treatments for rare and common conditions
8 January 2021 - The objectives of this study were to measure the relative societal importance of values of New Zealanders ...
Posted by Michael Wonder on 10 Jan 2021
Crohn's disease and colitis sufferers plead with PHARMAC to fund new drug
5 January 2021 - Sufferers of Crohn's disease and colitis are pleading with PHARMAC to fund a drug that's available ...
Posted by Michael Wonder on 01 Jan 2021
New Zealand Pharmaceutical Schedule - 1 January 2021
1 January 2021 - The January 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Dec 2020
Kiwis going into debt to pay for drugs other countries fund
21 December 2020 - An internal stoush at the drug-buying agency PHARMAC has blocked funding for a life-extending drug for bowel ...